Wolfe, Heather R. http://orcid.org/0000-0003-2076-6487
Rein, Lindsay A. M.
Funding for this research was provided by:
National Institutes of Health (T32 HL007057-44)
Article History
Accepted: 13 September 2021
First Online: 18 October 2021
Declarations
:
: Dr. Heather R. Wolfe has no conflict of interest to disclose; Dr. Lindsey Rein has received advisor/consultant fees from Novartis, Celgene Blueprints Medicine, and Clinical Care Options. Dr. Rein is the site principal investigator (PI) for clinical trials sponsored by the following companies/entities: SWOG, CTI BioPharma, Blueprints Medicine, Actuate Therapeutics, Celgene, Imago BioSciences, Incyte Corporation, Kiadis, and Sumitomo Dainippon Pharma Oncology.